Mingqiang Su
No. 19, Tanmulin Street, Ziliujing District
Zigong, 643000, China
Zigong, 643000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.
Journal: Urologic oncology
Published: December 24, 2025
E2F1-induced transcriptional activation of MAL2 inhibits sunitinib sensitivity and promotes the malignant progression of bladder cancer.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 27, 2025
Effect of EGR1/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma.
Journal: Briefings in functional genomics
Published: August 13, 2025
MCUB Inhibits PRKN-Dependent Mitophagic Degradation of PD-L1 to Promote Immune Evasion in Bladder Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 04, 2025
METTL3 promotes the progression of bladder cancer through the METTL3/IGF2BP3/MTA1/PI3K/AKT axis.
Journal: Pathology, research and practice
Published: July 20, 2025
SPC25 Activates the Warburg Effect to Inhibit Ferroptosis in Prostate Cancer Cells.
Journal: American journal of men's health
Published: November 19, 2024
Prognostic Value and Clinical Significance of Vesicular Transport-Related Genes in Clear Cell Renal Cell Carcinoma.
Journal: Kidney & blood pressure research
Published: November 21, 2023
Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes.
Journal: Journal of immunology research
Published: January 10, 2022
A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
Journal: Frontiers in immunology
Published: July 29, 2021
HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer.
Journal: American journal of translational research
Published: June 27, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026